Clinical Trial Update: Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating loratadine versus a diosmin/hesperidin combination for vincristine-related neuropathy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vinca Alkaloid-induced Neuropathy

Drugs mentioned

• Diosmin-Hesperidin
• Loratadine (Loratadine)

Snippet

Sponsor: Ain Shams University | Conditions: Vinca Alkaloid Adverse Reaction | Phase 3 | Status: UNKNOWN